Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 7—July 2013


Transmission of Streptococcus equi Subspecies zooepidemicus Infection from Horses to Humans

Sinikka Pelkonen1Comments to Author , Susanne B. Lindahl1, Päivi Suomala, Jari Karhukorpi, Sakari Vuorinen, Irma Koivula, Tia Väisänen, Jaana Pentikäinen, Tiina Autio, and Tamara Tuuminen
Author affiliations: Finnish Food Safety Authority Evira, Kuopio, Finland (S. Pelkonen, T. Autio); National Veterinary Institute, Uppsala, Sweden (S.B. Lindahl),; Swedish University of Agricultural Sciences, Uppsala (S.B. Lindahl); Eastern Finland Laboratory Centre Joint Authority Enterprise, Mikkeli, Finland (P. Suomala, T. Tuuminen); Eastern Finland Laboratory Centre Joint Authority Enterprise, Joensuu, Finland (J. Karhukorpi); Eastern Finland Laboratory Centre Joint Authority Enterprise, Kuopio (J. Pentikäinen); Mikkeli Central Hospital, Mikkeli (S. Vuorinen); Kuopio University Hospital, Kuopio (I. Koivula, T. Väisänen); University of Helsinki, Helsinki, Finland (T. Tuuminen)

Cite This Article


Highlight and copy the desired format.

EID Pelkonen S, Lindahl SB, Suomala P, Karhukorpi J, Vuorinen S, Koivula I, et al. Transmission of Streptococcus equi Subspecies zooepidemicus Infection from Horses to Humans. Emerg Infect Dis. 2013;19(7):1041-1048.
AMA Pelkonen S, Lindahl SB, Suomala P, et al. Transmission of Streptococcus equi Subspecies zooepidemicus Infection from Horses to Humans. Emerging Infectious Diseases. 2013;19(7):1041-1048. doi:10.3201/eid1907.121365.
APA Pelkonen, S., Lindahl, S. B., Suomala, P., Karhukorpi, J., Vuorinen, S., Koivula, I....Tuuminen, T. (2013). Transmission of Streptococcus equi Subspecies zooepidemicus Infection from Horses to Humans. Emerging Infectious Diseases, 19(7), 1041-1048.


CME Logo

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at; (4) view/print certificate.

Release date: June 28, 2013; Expiration date: June 28, 2014

Learning Objectives

Upon completion of this activity, participants will be able to:

• Evaluate the clinical presentation and outcomes of patients with Streptococcus equi zooepidemicus infection

• Analyze the transmission of S. zooepidemicus

• Distinguish molecular characteristics of S. zooepidemicus

CME Editor

Carol E. Snarey, MA, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Carol E. Snarey, MA, has disclosed no relevant financial relationships.

CME Author

Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.


Disclosures: Sinikka Pelkonen, Susanne B. Lindahl, Päivi Suomala, Jari Karhukorpi, Sakari Vuorinen, Irma Koivula, Tia Väisänen, Jaana, Tiina Autio, and Tamara Tuuminen have disclosed no relevant financial relationships.


Streptococcus equi subspecies zooepidemicus (S. zooepidemicus) is a zoonotic pathogen for persons in contact with horses. In horses, S. zooepidemicus is an opportunistic pathogen, but human infections associated with S. zooepidemicus are often severe. Within 6 months in 2011, 3 unrelated cases of severe, disseminated S. zooepidemicus infection occurred in men working with horses in eastern Finland. To clarify the pathogen’s epidemiology, we describe the clinical features of the infection in 3 patients and compare the S. zooepidemicus isolates from the human cases with S. zooepidemicus isolates from horses. The isolates were analyzed by using pulsed-field gel electrophoresis, multilocus sequence typing, and sequencing of the szP gene. Molecular typing methods showed that human and equine isolates were identical or closely related. These results emphasize that S. zooepidemicus transmitted from horses can lead to severe infections in humans. As leisure and professional equine sports continue to grow, this infection should be recognized as an emerging zoonosis.

Streptococcus equi subspecies zooepidemicus (S. zooepidemicus) is a β-hemolytic, Lancefield group C streptococcal bacterium. S. zooepidemicus is considered an opportunistic commensal in horses (13), but it may also cause infections in other domestic animals such as cattle, sheep, goats, pigs, dogs, and cats (410). Another subspecies of the same genus, Streptococcus equi subsp. equi (S. equi), causes strangles, the highly contagious and serious disease in horses (1,11,12).

S. zooepidemicus shares >98% DNA sequence homology with S. equi (1) and >80% DNA sequence homology with Streptococcus pyogenes (13), a Lancefield group A streptococcus and major human pathogen. Although considered an opportunistic pathogen, S. zooepidemicus shares important virulence factors with both S. equi and S. pyogenes such as the M-like proteins, superantigens (sAgs), and the presence of a hyaluronic acid capsule in certain strains. The variable M-protein, located on the surface of S. pyogenes, can be used to differentiate S. pyogenes strains serologically where the M1 serotype is associated with invasive disease in humans (14). The M-like, cell-wall–anchored surface protein SzP, found in all strains of S. zooepidemicus, is essential for the pathogenesis of the disease, at least in horses, where it binds fibrinogen and exhibits antiphagocytic activity that impairs with host protection. The sAgs SeeH, SeeI, SeeL, and SeeM found in S. equi share 96%–99% amino acid sequence homology with S. pyogenes sAgs SpeH, SpeI, SpeL, and SpeM (15). However, few investigated strains of S. zooepidemicus contain homologs to these sAgs. Instead, novel sAgs (SzeF, SzeN, and SzeP) have been identified in certain strains, sharing 34%–59% homology with SpeH, SpeM, and SpeL of S. pyogenes (16).

S. zooepidemicus has seldom been isolated from humans. Surprisingly, most published data on humans go back to the latter part of the 1980s (17). Occasional human infection was reported as a result of the consumption of homemade cheese or unpasteurized milk from cows with mastitis (17). In humans, S. zooepidemicus may cause glomerulonephritis and rheumatic fever, which are known sequelae of S. pyogenes (group A) infections (18). Meningitis and purulent arthritis have also been reported (19,20).

S. zooepidemicus displays a wide genetic variation between different isolates (13,2123). The sequence of the SzP protein gene (szP) has been shown to vary greatly between different strains of S. zooepidemicus (2426), and the variable regions of szP can be used to genetically differentiate strains within the subspecies (2729). Pulsed-field gel electrophoresis (PFGE) is a DNA-based typing technique that is highly discriminatory and has been used in epidemiologic investigations of S. zooepidemicus outbreaks (30,31).

Multilocus sequence typing (MLST) is a method for characterization of bacterial isolates by comparing sequences of several gene fragments. Webb et al. (22) developed a MLST protocol for S. zooepidemicus consisting of 7 housekeeping genes. Obtained sequences are compared to previously deposited sequences, and a sequence type (ST) is assigned from the online PubMLST S. zooepidemicus database ( developed by Jolley et al. (32).

Within a 6-month period, through our routine practice, we found 3 cases of severe disseminated disease in humans caused by S. zooepidemicus. The purpose of this study was to 1) characterize the clinical presentation of the disease caused by S. zooepidemicus, 2) microbiologically characterize the isolated strains, and 3) identify clonality of human isolates for comparison to equine isolates from contact horse stables and other horse farms of the surrounding area.

Patient 1

A 57-year-old man, a farmer and horse breeder from central Finland, was admitted unconscious and febrile to the emergency room of a principal hospital in February of 2011. Cerebrospinal fluid (CSF) was collected, and he was referred to the intensive care unit. He had aortic valve insufficiency and had been catheterized 3 months earlier. His condition was septic, with clinical symptoms of meningismus and pulmonary congestion. The C-reactive protein (CRP) level was 564 mg/L (reference <3 mg/L) and the leukocyte count 15.9 × 109 cells/L (reference 3.4–8.2 × 109 cells/L). Microscopy staining of the CSF revealed gram-positive cocci in chains with a considerable number of polymorphonuclear cells. The next day, bacteria subsequently identified as S. zooepidemicus (Table 1) grew from the CSF and 4 of the 4 blood culture bottles, leading to a primary diagnosis of meningitis and sepsis. Intravenous high-dose penicillin treatment (5 weeks) was started in combination with gentamicin (first 10 days). Two and a half days after admission, the patient regained consciousness. Intravascular coagulopathy developed, and 20 days later, progressive endocarditis. The bicuspid native aortic valve was resected the same day, and several bacterial patches were observed. His perioperative blood cultures remained negative. Neurologic sequelae did not develop, but his recovery and rehabilitation required several weeks.

Patient 2

A 62-year-old-man, a truck driver and horse trainer from eastern Finland, returned home from work in a febrile and confused state in May 2011. The next day, on hospital admission, he had pain and swelling of the right knee and right shoulder. He was hyperglycemic and had untreated non–insulin-dependent diabetes mellitus. The synovial fluid aspirated from his knee was turbid, with a leukocyte count of 86.0 × 109 cells/L and a high percentage of polymorphonuclear cells (87%). The CRP level was 329 mg/L and the blood leukocyte count was 19.3 × 109 cells/L. Antimicrobial drug therapy with intravenous cefuroxime was started. The next day, bacteria subsequently identified as S. zooepidemicus were cultured from his right knee and 4 of 4 blood culture bottles (Table 1). On the third day, arthroscopic synovectomy and irrigation of the right knee was performed, and the procedure was repeated. Cefuroxime was changed to intravenous vancomycin without therapeutic response. The CRP level remained high (229 mg/L) and the leukocyte count was 15.3 × 109 cells/L. Next, a combination of penicillin G with clindamycin was administered. He had no evidence of endocarditis, but Tc99m scintigraphy revealed an uptake in the patient’s right shoulder and lower jaw region. Arthroscopic debridement and irrigation of the right shoulder were performed, and purulent synovial fluid was collected for culture. Antimicrobial drug therapy continued with intravenous cefuroxime and clindamycin for 2 weeks; thereafter, with oral cephalexin and clindamycin for 1 week. The patient’s clinical condition gradually improved, and finally, he was able to walk with crutches. He was discharged from the hospital 6 weeks after the onset of illness.

Patient 3

A 49-year-old man, a horse trainer from eastern Finland, was admitted to the hospital in August 2011 because of severe, prolonged low-back pain. A horse had kicked his forehead 2–3 weeks earlier. The accident did not require medical attention at that time; however, the low-back pain had increased gradually. He had medicated himself with ibuprofen, 400 mg up to 20 tablets per day, without relief, except when lying supine. He did not record his temperature but was sweating after taking ibuprofen and sought medical attention when walking became difficult. His condition was treated as muscle pain. After a week he returned to the medical center because of excruciating pain in his back. There were no abnormal radiologic findings. On clinical examination, he was nonfebrile and had no clinical symptoms or hemodynamic abnormalities. The clinical findings were unremarkable, except for the pain in his lower back on percussion and a pulsating abdominal mass. Laboratory tests showed leukocytosis (16.2 × 109 cells/L), an elevated erythrocyte sedimentation rate of 73 mm/h (reference 115 mm/h), and an elevated CRP level of 217 mg/L. Computed tomography revealed a psoas abscess (65 × 35 × 30 mm) linked to an infected aortic aneurysm (diameter 40 mm). The aneurysm was resected and replaced by a Y-prosthesis, and the psoas abscess was drained. Gram stain of tissue obtained through operation on the abdominal aorta and debridement of the psoas abscess revealed gram-positive cocci in 3 (2 from the aortic wall and 1 from the psoas abscess) of the 4 samples. The patient’s condition was treated with piperacillin-tazobactam, later replaced with intravenous penicillin. Transesophageal echocardiography showed no signs of endocarditis. The patient recovered without sequelae.

Materials and Methods

Microbiological Diagnostics of S. zooepidemicus Strains in Clinical Laboratories

Each clinical laboratory used the standard operating procedures and standard culture media of their own. CSF and synovial fluid samples were cultured on blood and/or chocolate agar and blood samples in blood culture bottles and incubated aerobically and anaerobically. For identification, Gram stain and agglutination with streptococcal group sera (Streptococcal Grouping Kit; Oxoid Ltd., Basingstoke, UK) were carried out in all laboratories. The identification of S. zooepidemicus to the species level varied between the laboratories, and was performed using at least one of the following tests as shown in Table 1: APIStrep, , STR Rapid ID32, or VITEK2 GP-ID (all from bioMérieux Marcy l’Etoile, France), combined with AccuProbe Group B Streptococcus Culture ID Test (Gen-Probe, San Diego, CA, USA).

Antibiotic Susceptibility of Human Isolates

The antibiotic susceptibility profiles were studied with the disk diffusion method (patients 1 and 3) or Etest (patient 2). Results were interpreted according to the EUCAST rules (

Collection and Microbiological Characterization of Equine Isolates

None of the horses from the stables associated with the first 2 human cases (patients 1 and 2) showed any signs of respiratory illness. The horses from the third stable (owned by patient 3) were not examined; however, the owner did not recall any clinical signs of respiratory or other disease in his horses. Nasal swab specimens were collected from 7 horses owned by patient 1 (stable A) and 4 horses owned by patient 2 (stable H). The swabs were streaked onto bovine blood agar plates and incubated in a 5% CO2 atmosphere at 37°C (according to the standard operating procedures of the Finnish Food Safety Authority Evira, Kuopio, Finland) for 24 hours. β-hemolytic colonies were studied with conventional methods, and biochemical characterization was performed by using Rapid ID32 Strep (bioMérieux). S. zooepidemicus was isolated from 5 horses in stable A, but not from any horse in stable H. Six other S. zooepidemicus isolates from horses unrelated to the described human cases (stables B to F) (Table 2) were included in the genetic comparison.

Pulsed-field Gel Electrophoresis

Three human isolates (1 from each patient) and 11 equine isolates of S. zooepidemicus were investigated by PFGE, sequencing of the szP gene, and MLST. DNA isolation was performed as described by Elliot et al. (33), and 40 U of SmaI was used for digestion. The chromosomal digests were separated by PFGE, with a switch time of 5 to 40 s for 20 h at a 120° angle and a voltage gradient of 6 V/cm at 12°C. Chromosomal DNA of Salmonella enterica serovar Braenderup H9182 was used as a marker.

Sequencing of the szP gene and MLST

Isolates of S. zooepidemicus were cultured on 5% horse blood agar (National Veterinary Institute, Uppsala, Sweden) in a 5% CO2 atmosphere at 37°C for 24 h. Preparation of DNA from bacterial culture was performed by a boiling procedure; a 1-μL loop of bacteria was suspended in 100 μL of sterile H2O and incubated at 98°C for 15 min. The samples were centrifuged and the supernatants were collected and used as templates in the sequencing analyses.

The isolates of S. zooepidemicus (n = 14) were investigated by sequencing a 373-bp fragment of the SzP protein gene (25). Sequencing was performed according to Båverud et al. (34). Sequences were edited, assembled, and analyzed by using BioNumerics 6.5 (Applied Maths, Saint-Martens-Latem, Belgium).

MLST was performed according to Webb et al. (22). Sequences were edited, assembled, and analyzed by using BioNumerics 6.5. Sequence types (STs) were determined using the PubMLST S. zooepidemicus database.


Microbiological Identification and Antibiotic Susceptibility of Human Isolates

The colonies of S. zooepidemicus on blood agar were large and mucoid and had a wide zone of β-hemolysis. All isolates were sensitive to erythromycin, clindamycin, penicillin, vancomycin, and cephalexin (data not shown). Microbiological identification data for the S. zooepidemicus isolates from human cases are shown in Table 1.

Molecular Characterization of Isolates

Figure 1

Thumbnail of eBURST diagram ( of all multilocus sequence typing (MLST) sequence types (STs) for Streptococcus equi subspecies zooepidemicus and S. equi subsp. equi recorded in the PubMLST database ( (February 7, 2013). Single-locus variants (SLVs) are connected by a solid line. Black circles indicate strains isolated in this study from human cases and 1 horse (ST-10: Hum1, horse isolate 648/11, and Hum2; ST-209: Hum3 isolate). Gray circles

Figure 1. . . . . . . eBURST diagram ( of all multilocus sequence typing (MLST) sequence types (STs) for Streptococcus equi subspecies zooepidemicus and S. equi subsp. equi recorded in...

The S. zooepidemicus isolates displayed 10 ST types by MLST. Their relatedness was compared by using eBurst ( of all MLST STs for S. equi subsp. zooepidemicus and S. equi subsp. equi recorded in the PubMLST S. zooepedemicus database (February 7, 2013) (Figure 1). eBurst analysis indicated that ST-10, displayed by 3 isolates, Hum1, Hum2, and equine 648/11, was not related to any other STs of the S. zooepidemicus isolates examined in this study (Figure 1; Table 2). ST-209 and ST-201 are double-locus variants (DLVs) and were displayed by Hum3 isolate and horse isolate 6939/10, respectively. All other detected STs were unrelated to each other. Isolates from stables E (8110/09) and F (7723/09) displayed STs not previously described in the PubMLST S. zooepedemicus database. In addition, no product was obtained from forward and reverse primers for the yqiL gene from the isolate from stable F (7723/09).

Figure 2

Thumbnail of Pulsed-field gel electrophoresis of Streptococcus equi subspecies zooepidemicus isolates using SmaI. The lanes are marked with the number of the respective isolate. DNA of Salmonella enterica serovar Braenderup H9182 was used as a molecular marker.

Figure 2. . . . . . . Pulsed-field gel electrophoresis of Streptococcus equi subspecies zooepidemicus isolates using SmaI. The lanes are marked with the number of the respective isolate. DNA of Salmonella...

The human isolates Hum1 (patient 1) and Hum2 (patient 2) displayed an szP sequence (GenBank accession no. AF519489) and MLST sequence type (ST-10) identical to the equine isolate 648/11 (stable A) (Table 2). Hum1 was also identical to equine isolate 648/11 on PFGE (Figure 2). Hum2, however, differed from Hum1 and 648/11 by 6 bands on the PFGE profile. The third human isolate, Hum3 (patient 3), was closely related to 1 equine isolate (6939/10) from an unrelated stable (stable D). These isolates displayed an identical szP sequence (accession no. AF519488). Their PFGE profiles were almost identical, and the MLST types ST-209 (Hum3) and ST-201 (6939/10) were DLVs. None of the other equine isolates displayed the same szP sequence type or MLST STs as the human isolates. Among the 5 S. zooepidemicus isolates from stable A, 645/11 was identical to 647/11 on the basis of the MLST ST (ST-175), szP type (II), and PFGE profile. All other isolates differed from each other. Several equine isolates displayed szP sequences not previously described in GenBank (645/11, 646/11, 647/11, and 1128). All szP sequencing results and corresponding GenBank accession numbers are listed in Table 2.


We report 3 unrelated cases of S. zooepidemicus infection in patients from eastern Finland who had close and continuous contact with horses. It is noteworthy that the disease in all 3 patients was invasive and severe, requiring prolonged treatment and rehabilitation. Sepsis occurred in 2 cases (patients 1 and 2), meningitis and endocarditis in 1 (patient 1), purulent arthritis in 1 (patient 2), and a psoas abscess in connection with an aortic wall infection in 1 (patient 3). In patient 3, transient bacteremia might have occurred earlier.

MLST, PFGE, and sequencing of the SzP protein gene demonstrated identical profiles in a human isolate (Hum1) with an equine isolate (648/11), which strongly supports the zoonotic nature of this disease. Notably, the strain (ST-10) colonized the horse’s nostrils and acted as an innocent commensal, whereas in humans this strain appeared highly virulent and caused severe illness. In the second case (patient 2), we were unable to isolate the same strain from his horses. This failure may have been due to a transient S. zooepidemicus carriage in the nasopharynx, lymphoid tissues, or respiratory tract of the horse. Patient 2 might have been in contact with other horses as well. The strains from patient 1 and patient 2 were identical according to both szP sequencing and MLST, which supports the close relationship between the Hum1 and Hum2 isolates, and although the 2 isolates differed on PFGE analysis (Figure 1), the data strongly suggest that the infection of patient 2 was also transmitted zoonotically. ST-10 is a single-locus variant (SLV) of ST-72, which previously has been isolated from a case of human nephritis in the UK in 1983 (, and from a large outbreak of severe human nephritis in Brazil during 1997 and 1998 associated with consumption of unpasteurized cheese (13,35,36). The isolated strain in the Brazil outbreak was shown to have several genetic similarities to group A streptococci (35).

PFGE reveals random genetic events, such as point mutations or insertions or deletions of genetic material (37), thereby being often a more sensitive method than MLST to identify recent epidemic strains. However, it is not possible to estimate whether S. zooepidemicus isolates from patients 1 and 2, with altered PFGE profiles and approximately a 3-months’ gap between the diagnoses of disease, could be of the same origin. Notably, the strain isolated from patient 3 (Hum3), which differed completely from Hum1 and Hum2, was identical by MLST (ST-209) to a strain isolated from horses in an outbreak of respiratory disease in Iceland in 2010 (Bjornsdottir et al., unpub data). The Hum3 isolate also shared a szP sequence type (accession no. AF519488) previously found in horses with respiratory disease (S.B. Lindahl, unpub. data) as well as in an asymptomatic horse (6939/10) in this study. The ST-209 strain has further been isolated from a person with septicemia (that was associated with abortion) in Iceland in 2010, and has a SLV (ST-200) and a DLV (ST-201) that have been reported from cases of abortion/uterine infections in horses ( The ST-201 was also found in one of the healthy horses in this study (Table 2).

All strains of S. zooepidemicus displayed mucoid colonies on the agar plates, indicating expression of a hyaluronic acid capsule, a well-known virulence factor in other pathogenic streptococci, such as S. equi in horses and S. pyogenes in humans. However, the expression of the mucoid capsule was variable: Hum1 strain produced large and highly mucous colonies, whereas those from Hum3 were heterogeneous in colony size and less mucoid. Whether there is a correlation between the production of mucinous substance and severity of the disease remains to be determined. Additional virulence factors, such as the presence of sAgs (16), would be intriguing to investigate. In S. pyogenes, variation in the M-protein is attributed to variable virulence. For example, the M1 strains are the most pathogenic (14). The sequence variants of the SzP protein gene in S. zooepidemicus were investigated but could not be correlated with clinical features in horses in a study by Walker and Runyan (26). However, determining such a correlation might be possible for the human isolates.

Recently, an outbreak of invasive S. zooepidemicus infection has been reported from Finland by Kuusi et al. (30). Altogether, 7 patients were identified: 6 had septicemia and 1 had purulent arthritis. All had consumed goat cheese produced from unpasteurized milk in a small-scale dairy. In Finland (population 5.2 million), all invasive streptococcal infections must be reported to the National Infectious Disease Register. As reviewed by Kuusi et al., only 3 cases of invasive S. zooepidemicus infections were reported to the register from 1992 through 2002, and ≈10 cases of invasive group C streptococcal infections occurred annually. In other words, even invasive isolates were often typed only to the Lancefield group level.

The novelty of our investigation is that an identical S. zooepidemicus strain was isolated from patient 1 and from a healthy horse in his stable, suggesting zoonotic transmission. Furthermore, patient 2 was infected with a S. zooepidemicus strain clonally related to that of patient 1, as judged by 2 independent typing methods, although patients 1 and 2 lived 140 km apart without a verified contact with each other. Notably, the isolate from patient 1 was highly virulent in humans but did not cause any clinical infection in the horse. In contrast, the isolate from patient 3 had the same MLST type as the strain previously isolated from several horses in an outbreak of respiratory disease. Our work yielded 3 new sequences of the szP gene, deposited under GenBank accession nos. KC287220 (isolate 645/11), KC287221 (isolate 646/11), and KC287222 (isolate 1128/11). Further, isolate 8110/09 was added to the PubMLST S. zooepidemicus database with ST-299. The isolate 7723/09 could not be assigned a ST because there was no product for the yqiL gene; however, the isolate is recorded in the PubMLST S. zooepidemicus database with the following allele sequence: 8 (arcC)–52 (nrdE)–2 (proS)–14 (spi)–1 (tdk)–22 (tpi)–n/a (yqiL).


Leisure and professional equine sports activities are growing in many countries. S. zooepidemicus infection transmitted from horses may cause severe illness in humans and should be considered an emerging zoonosis. Bacteriological identification of S. zooepidemicus is cheap and feasible with simple fermentation methods. Therefore, typing to the species level is strongly recommended for all clinical laboratories whenever group C streptococci are recovered from severely infected persons. Early identification of S. zooepidemicus will facilitate appropriate medical intervention and timely epidemiologic surveillance and finally, prevent the spread of a potentially life-threatening pathogen.

Dr Pelkonen is the head of Veterinary Bacteriology Research Unit, Research and Laboratory Department, Finnish Food Safety Authority, Finland. Her research is focused on bacterial infections in animals and bacterial zoonoses.


Sofia Lindström and Robert Söderlund, National Veterinary Institute, Uppsala, Sweden, are acknowledged for technical support in sequencing of the SzP protein gene and performing MLST. We are grateful to Tiina Kortelainen and Sirpa Heinikainen for PFGE analyses.

S.B.L.’s work was supported by FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning).

T.A., S.B.L., and T.T. conceived and wrote the first draft; P.S., T.T., J.K. isolated the human strains; T.A. and S.P. isolated the equine strains; S.V., I.K., T.V., and J.K. processed patient records; S.B.L. performed the SzP sequencing and MLST analyses; S.P. and T.A. performed PFGE analysis; T.T. designed the study. All authors contributed to manuscript preparation and approved the final version. The analysis of data presented here is a part of our routine effort endorsed by the Finnish Law, to prevent the spread of transmissible diseases. Therefore, a special permission from the Ethical Committee of the Eastern Finland region was not considered necessary. Verbal or written informed consent for the study was obtained from the patients.


  1. Timoney JF. The pathogenic equine streptococci. Vet Res. 2004;35:397409. DOIPubMed
  2. Laus F, Preziuso S, Spaterna A, Beribe F, Tesei B, Cuteri V. Clinical and epidemiological investigation of chronic upper respiratory diseases caused by beta-haemolytic streptococci in horses. Comp Immunol Microbiol Infect Dis. 2007;30:24760. DOIPubMed
  3. Newton JR, Laxton R, Wood JL, Chanter N. Molecular epidemiology of Streptococcus zooepidemicus infection in naturally occurring equine respiratory disease. Vet J. 2008;175:33845. DOIPubMed
  4. Blum S, Elad D, Zukin N, Lysnyansky I, Weisblith L, Perl S, Outbreak of Streptococcus equi subsp. zooepidemicus infections in cats. Vet Microbiol. 2010;144:2369. DOIPubMed
  5. Fan H, Wang Y, Tang F, Lu C. Determination of the mimic epitope of the M-like protein adhesin in swine Streptococcus equi subsp. zooepidemicus. BMC Microbiol. 2008;8:170. DOIPubMed
  6. Lamm CG, Ferguson AC, Lehenbauer TW, Love BC. Streptococcal infection in dogs: a retrospective study of 393 cases. Vet Pathol. 2010;47:38795. DOIPubMed
  7. Las Heras A, Vela AI, Fernandez E, Legaz E, Dominguez L, Fernandez-Garayzabal JF. Unusual outbreak of clinical mastitis in dairy sheep caused by Streptococcus equi subsp. zooepidemicus. J Clin Microbiol. 2002;40:11068. DOIPubMed
  8. Pisoni G, Zadoks RN, Vimercati C, Locatelli C, Zanoni MG, Moroni P. Epidemiological investigation of Streptococcus equi subspecies zooepidemicus involved in clinical mastitis in dairy goats. J Dairy Sci. 2009;92:94351. DOIPubMed
  9. Priestnall S, Erles K. Streptococcus zooepidemicus: an emerging canine pathogen. Vet J. 2011;188:1428. DOIPubMed
  10. Sharp MW, Prince MJ, Gibbens J. S. zooepidemicus infection and bovine mastitis. Vet Rec. 1995;137:128. DOIPubMed
  11. Harrington DJ, Sutcliffe IC, Chanter N. The molecular basis of Streptococcus equi infection and disease. Microbes Infect. 2002;4:50110. DOIPubMed
  12. Sweeney CR, Timoney JF, Newton JR, Hines MT. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. J Vet Intern Med. 2005;19:12334 .PubMed
  13. Holden MT, Heather Z, Paillot R, Steward KF, Webb K, Ainslie F, Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog. 2009;5:e1000346 . DOIPubMed
  14. Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol. 2011;9:72436. DOIPubMed
  15. Paillot R, Robinson C, Steward K, Wright N, Jourdan T, Butcher N, Contribution of each of four Superantigens to Streptococcus equi–induced mitogenicity, gamma interferon synthesis, and immunity. Infect Immun. 2010;78:172839. DOIPubMed
  16. Paillot R, Darby AC, Robinson C, Wright NL, Steward KF, Anderson E, Identification of three novel superantigen-encoding genes in Streptococcus equi subsp. zooepidemicus, szeF, szeN, and szeP. Infect Immun. 2010;78:481727. DOIPubMed
  17. Mandell GL, Bennet JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995.
  18. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology. 9th ed. Washington (DC): ASM Press; 2007.
  19. Eyre DW, Kenkre JS, Bowler IC, McBride SJ. Streptococcus equi subspecies zooepidemicus meningitis–a case report and review of the literature. Eur J Clin Microbiol Infect Dis. 2010;29:145963. DOIPubMed
  20. Friederichs J, Hungerer S, Werle R, Militz M, Buhren V. Human bacterial arthritis caused by Streptococcus zooepidemicus: report of a case. Int J Infect Dis. 2010;14(Suppl 3):e2335. DOIPubMed
  21. Chanter N, Collin N, Holmes N, Binns M, Mumford J. Characterization of the Lancefield group C streptococcus 16S–23S RNA gene intergenic spacer and its potential for identification and sub-specific typing. Epidemiol Infect. 1997;118:12535. DOIPubMed
  22. Webb K, Jolley KA, Mitchell Z, Robinson C, Newton JR, Maiden MC, Development of an unambiguous and discriminatory multilocus sequence typing scheme for the Streptococcus zooepidemicus group. Microbiology. 2008;154:301624. DOIPubMed
  23. Barquero N, Chanter N, Laxton R, Wood JL, Newton JR. Molecular epidemiology of Streptococcus zooepidemicus isolated from the respiratory tracts of Thoroughbred racehorses in training. Vet J. 2010;183:34851. DOIPubMed
  24. Timoney JF, Anzai T, Blair M. Clonal invasion of the equine respiratory tract by Streptococcus zooepidemicus. Adv Exp Med Biol. 1997;418:6113 .PubMed
  25. Anzai T, Timoney JE, Kuwamoto Y, Wada R, Oikawa M, Higuchi T. Polymerase chain reaction-restriction fragment length polymorphism analysis of the SzP gene of Streptococcus zooepidemicus isolated from the respiratory tract of horses. Am J Vet Res. 2002;63:1298301. DOIPubMed
  26. Walker RL, Runyan CA. Identification of variations in SzP proteins of Streptococcus equi subspecies zooepidemicus and the relationship between protein variants and clinical signs of infection in horses. Am J Vet Res. 2003;64:97681. DOIPubMed
  27. Akineden O, Hassan AA, Alber J, El-Sayed A, Estoepangestie AT, Lammler C, Phenotypic and genotypic properties of Streptococcus equi subsp. zooepidemicus isolated from harbor seals (Phoca vitulina) from the German North Sea during the phocine distemper outbreak in 2002. Vet Microbiol. 2005;110:14752. DOIPubMed
  28. Akineden O, Alber J, Lammler C, Weiss R, Siebert U, Foster G, Relatedness of Streptococcus equi subsp. zooepidemicus strains isolated from harbour seals (Phoca vitulina) and grey seals (Halichoerus grypus) of various origins of the North Sea during 1988–2005. Vet Microbiol. 2007;121:15862 . DOIPubMed
  29. Nicholson ML, Ferdinand L, Sampson JS, Benin A, Balter S, Pinto SW, Analysis of immunoreactivity to a Streptococcus equi subsp. zooepidemicus M-like protein To confirm an outbreak of poststreptococcal glomerulonephritis, and sequences of M-like proteins from isolates obtained from different host species. J Clin Microbiol. 2000;38:412630 .PubMed
  30. Kuusi M, Lahti E, Virolainen A, Hatakka M, Vuento R, Rantala L, An outbreak of Streptococcus equi subspecies zooepidemicus associated with consumption of fresh goat cheese. BMC Infect Dis. 2006;6:36 . DOIPubMed
  31. Bordes-Benítez A, Sanchez-Onoro M, Suarez-Bordon P, Garcia-Rojas AJ, Saez-Nieto JA, Gonzalez-Garcia A, Outbreak of Streptococcus equi subsp. zooepidemicus infections on the island of Gran Canaria associated with the consumption of inadequately pasteurized cheese. Eur J Clin Microbiol Infect Dis. 2006;25:2426. DOIPubMed
  32. Jolley KA, Chan MS, Maiden MC. mlstdbNet-distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics. 2004;5:86 . DOIPubMed
  33. Elliott JA, Farmer KD, Facklam RR. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol. 1998;36:21156 .PubMed
  34. Båverud V, Johansson SK, Aspan A. Real-time PCR for detection and differentiation of Streptococcus equi subsp. equi and Streptococcus equi subsp. zooepidemicus. Vet Microbiol. 2007;124:21929 . DOIPubMed
  35. Beres SB, Sesso R, Pinto SW, Hoe NP, Porcella SF, Deleo FR, Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS ONE. 2008;3:e3026 . DOIPubMed
  36. Baiter S, Benin A, Pinto SW, Teixeira LM, Alvim GG, Luna E, Epidemic nephritis in Nova Serrana, Brazil. Lancet. 2000;355:177680 . DOIPubMed
  37. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:22339 .PubMed



Follow Up

Earning CME Credit

To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 70% passing score) and earn continuing medical education (CME) credit, please go to Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers. You must be a registered user on If you are not registered on, please click on the New Users: Free Registration link on the left hand side of the website to register. Only one answer is correct for each question. Once you successfully answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content of this activity, contact the accredited provider, For technical assistance, contact American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please refer to The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the certificate and present it to your national medical association for review.

Article Title:
Transmission of Streptococcus equi Subspecies zooepidemicus Infection
from Horses to Human

CME Questions

1. You are seeing a 50-year-old male who works as a horse trainer. The patient has a 2-week history of malaise, back and neck pain, and fever. He had thought he had the flu, but his wife noticed that he was confused and lethargic this morning and brought him to the doctor’s office.

You consider whether this patient might have an infection with Streptococcus equi zooepidemicus. S. zooepidemicus was associated with all of the following sites of infection in the current case series EXCEPT:

A. Throat

B. Joint

C. Soft tissue

D. Central nervous system/meningitis

2. What should you consider regarding the clinical course of patients with S. zooepidemicus infection in the current study?

A. None of the patients had recent exposure to horses

B. All patients died of the infection

C. There was broad antimicrobial resistance of S. zooepidemicus isolates

D. All patients had objective findings of systemic inflammation

3. The patient is admitted to hospital, and his blood culture grows S. zooepidemicus. What should you consider regarding the transmission of this infection?

A. S. zooepidemicus is only found in horses and humans

B. Half of the horses found to harbor S. zooepidemicus in the current study were sick

C. Two patients in the current study were infected with the same strain of S. zooepidemicus despite living over 100 km from each other

D. All 3 patients in the current study were infected with the same strain of S. zooepidemicus

4. As you treat this patient, what should you consider regarding molecular findings from the current study?

A. Gene sequencing failed to connect human with equine isolates

B. Pulsed-field gel electrophoresis profiles were similar for the same strain of S. zooepidemicus

C. All multilocus sequence typing (MLST) sequence types correlated to known sequences of S. zooepidemicus

D. One strain was similar on MLST to a strain associated with a previous disease outbreak

Activity Evaluation

1. The activity supported the learning objectives.

Strongly Disagree

Strongly Agree






2. The material was organized clearly for learning to occur.

Strongly Disagree

Strongly Agree






3. The content learned from this activity will impact my practice.

Strongly Disagree

Strongly Agree






4. The activity was presented objectively and free of commercial bias.

Strongly Disagree

Strongly Agree






Cite This Article

DOI: 10.3201/eid1907.121365

1These authors contributed equally to this article.

Table of Contents – Volume 19, Number 7—July 2013

Article Navigation


Please use the form below to submit correspondence to the authors or contact them at the following address:

Sinikka Pelkonen, Veterinary Bacteriology, Research and Laboratory Department, Finnish Food Safety Authority Evira, Neulaniementie 4, FI-70210 Kuopio, Finland

character(s) remaining.

Comment submitted successfully, thank you for your feedback.